Benzinga
Evaluating G1 Therapeutics: Insights From 5 Financial Analysts - G1 Therapeutics (NASDAQ:GTHX)
Return on Assets (ROA): G1 Therapeutics's financial strength is reflected in its exceptional ROA, which exceeds industry...known as analyst ratings for stocks. Typically, analysts will rate ...
4 days ago